FilingReader Intelligence
KPC Pharmaceuticals revenue falls 12% in first half
August 15, 2025 at 10:40 AM UTC•By FilingReader AI
KPC Pharmaceuticals reported operating revenue fell 11.68% to RMB 3.35 billion for the first half of 2025, while net profit attributable to shareholders dropped 26.88% to RMB 198 million.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
SSE:600422•Shanghai Stock Exchange
News Alerts
Get instant email alerts when KPC Pharmaceuticals Inc publishes news
Free account required • Unsubscribe anytime